Cancer blood test trial begins in 200 GP practices

Getty Images

An NHS trial to test the effectiveness of a blood test to detect a range of cancers is being rolled out across 200 GP practices.

More than 20,000 patients will take place in the study to assess whether a blood test can spot prostate, ovarian, bowel, pancreatic, stomach, liver and other abdominal cancers.

The STRIDE-RCT study, backed by £8.49m of Government funding and run by the University of Birmingham will be offered to patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating or discomfort.

A single sample will be used to look for early protein markers of cancer, researchers said.

Practices involved have been selected to cover a broad range of inner-city, rural, seaside and deprived communities.

The cancers covered by the trial include bowel, small bowel, stomach, oesophageal, pancreatic, liver, bile duct and gallbladder, ovarian, endometrial, kidney, bladder and prostate.

Those leading the trial said they will investigate how well the tests work alongside GPs’ judgement before an assessment is made on rolling them out nationwide. 

A positive result will help the GP decide whether an urgent referral is needed but will not by itself a confirmed cancer diagnosis, they added.

Currently, just 2% to 6% of urgent referrals for cancer result in a diagnosis.

By giving GPs another tool to decide who needs further tests, the technology looks to reduce this figure and free up appointments for those with a genuinely urgent need, they said.

Professor Aneel Bhangu, consultant colorectal surgeon and co-chief investigator, said: ‘Too many patients with cancer reach me after months of vague symptoms that were hard to pin down.

‘At the same time, most people referred urgently do not have cancer, causing unnecessary worry and expense.

‘These blood tests might help GPs tell the two apart, but we need to know for certain before they are used across the NHS, and this trial is designed to give that answer quickly.’

Health secretary Yvette Cooper said: ‘The earlier cancers are diagnosed, the more chance they can be successfully treated, and lives can be saved.

‘This world-first trial will establish whether simple blood tests can help GPs identify much sooner the patients who need urgent support.’

Last year mixed trial results of a blood test to detect more than 50 types of cancer sparked debate about how it might best be used in practice.

It followed an NHS trial of the Galleri blood test which showed promising results.